CellsCancer BiologyPeer-reviewed journal article
Differential occupancy and regulatory interactions of KDM6A in bladder cell lines
G. Ozden-Yilmaz, B. Savas, A. Bursali, A. Eray, A. Aribas, S. Senturk, E. Karaca, G. Karakulah, S. Erkek-Ozhan
Abstract
Epigenetic deregulation is a critical theme which needs further investigation for bladder cancer research. One of the highly mutated genes in bladder cancer is KDM6A, functioning as a H3K27 demethylase and is part of the MLL3/4 complexes. To decipher the role of KDM6A in normal versus tumor setting, we identified the genomic landscape of KDM6A in normal, immortalized and cancer bladder cells. Our results showed differential KDM6A occupancy at the genes involved in cell differentiation, chromatin organization and Notch signaling depending on the cell type and the mutation status of KDM6A. Transcription factor motif analysis revealed HES1 to be enriched at KDM6A peaks identified for T24 bladder cancer cell line, which has a truncating mutation in KDM6A, lacking demethylase domain. Our co-immunoprecipitation experiments reveal TLE co-repressors and HES1 as potential truncated and wild type KDM6A interactors. With the aid of structural modeling, we explored how the truncated KDM6A could interact with TLE, HES1, as well RUNX, HHEX transcription factors. These structures provide a solid mean to study the functions of KDM6A independent of its demethylase activity. Collectively, our work provides important contributions to the understanding of KDM6A malfunction in bladder cancer.
- organism: human
- assay: ChIP-seq
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of KDM6A-mediated genomic instability and metabolic reprogramming differentially regulates responses to immune checkpoint therapy and chemotherapy in bladder cancer.
Pratishtha Singh, Ranit D’Rozario, … Sangeeta Goswami·Nature CommunicationsPeer-reviewed·Jan 7, 2026
- Paternal regulation of H3K4 methylation supports tumor suppressor networks in mammals intergenerationally
Benjamin William Walters, Rachel A. Heuer, … Bluma J. Lesch·bioRxiv·Sep 1, 2026
- KDM6A Regulates Immune Response Genes in Multiple Myeloma
D. Dupere-Richer, A. Riva, … J. D. Licht·bioRxiv·Feb 12, 2024
- Histone demethylome map reveals combinatorial gene regulatory functions in embryonic stem cells
Yogesh Kumar, Pratibha Tripathi, … Partha Pratim Das·bioRxiv·Aug 27, 2020
- KDM2B Silencing Elicits a Paracrine Mechanism Which Destabilizes SLUG, Promoting Differentiation of Basal-Like Breast Cancer Cells.
E.-A. Fraile, B. Soysal, … P. N. Tsichlis·bioRxiv·May 21, 2020
- KDM6A is enzymatically active at the Golgi apparatus where it is necessary for maintenance of Golgi apparatus morphology
Charli S Worth, Jessica M Conforti, … Joe Taube·bioRxiv·Nov 4, 2026